Concepts (75)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endothelium | 1 | 2008 | 158 | 0.310 |
Why?
|
| Cell Communication | 1 | 2008 | 509 | 0.260 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2013 | 1498 | 0.230 |
Why?
|
| Endothelial Cells | 3 | 2013 | 1048 | 0.210 |
Why?
|
| Cell Lineage | 2 | 2013 | 668 | 0.160 |
Why?
|
| Genes, Reporter | 2 | 2009 | 798 | 0.140 |
Why?
|
| Signal Transduction | 3 | 2013 | 11965 | 0.130 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 4 | 1 | 2015 | 45 | 0.130 |
Why?
|
| Stem Cells | 2 | 2013 | 1213 | 0.130 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Kinase | 1 | 2015 | 59 | 0.130 |
Why?
|
| Endothelium, Lymphatic | 1 | 2013 | 14 | 0.120 |
Why?
|
| Aldehyde Oxidoreductases | 2 | 2013 | 34 | 0.110 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2013 | 287 | 0.110 |
Why?
|
| Receptor, Notch1 | 1 | 2013 | 218 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2013 | 479 | 0.100 |
Why?
|
| Regenerative Medicine | 1 | 2011 | 49 | 0.100 |
Why?
|
| Tretinoin | 2 | 2013 | 623 | 0.090 |
Why?
|
| Endothelium, Vascular | 1 | 2013 | 891 | 0.080 |
Why?
|
| Genetic Techniques | 1 | 2009 | 130 | 0.080 |
Why?
|
| Cell Differentiation | 3 | 2013 | 4078 | 0.080 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2013 | 1242 | 0.080 |
Why?
|
| DNA Nucleotidyltransferases | 1 | 2007 | 31 | 0.070 |
Why?
|
| Hematopoiesis | 1 | 2008 | 560 | 0.070 |
Why?
|
| Heterozygote | 1 | 2008 | 1020 | 0.060 |
Why?
|
| Polymorphism, Genetic | 1 | 2009 | 1450 | 0.060 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2015 | 2027 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 1 | 2009 | 3101 | 0.050 |
Why?
|
| Flow Cytometry | 1 | 2008 | 3033 | 0.050 |
Why?
|
| Mice, Transgenic | 1 | 2008 | 4143 | 0.050 |
Why?
|
| Neovascularization, Physiologic | 2 | 2013 | 345 | 0.050 |
Why?
|
| Models, Biological | 1 | 2008 | 3254 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2015 | 8873 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 2007 | 3154 | 0.040 |
Why?
|
| Liver Neoplasms | 1 | 2015 | 4557 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2009 | 4549 | 0.040 |
Why?
|
| Animals | 5 | 2015 | 59536 | 0.030 |
Why?
|
| Mice | 3 | 2015 | 34495 | 0.030 |
Why?
|
| Mice, Inbred Strains | 1 | 2015 | 521 | 0.030 |
Why?
|
| Time Factors | 1 | 2008 | 12926 | 0.030 |
Why?
|
| Embryo Culture Techniques | 1 | 2013 | 35 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-myb | 1 | 2013 | 47 | 0.030 |
Why?
|
| Lac Operon | 1 | 2013 | 122 | 0.030 |
Why?
|
| Lentivirus | 1 | 2013 | 169 | 0.030 |
Why?
|
| Lymphangiogenesis | 1 | 2013 | 46 | 0.030 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2013 | 217 | 0.030 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2013 | 278 | 0.030 |
Why?
|
| Biopsy, Needle | 1 | 2015 | 1363 | 0.020 |
Why?
|
| Pluripotent Stem Cells | 1 | 2011 | 123 | 0.020 |
Why?
|
| Embryonic Stem Cells | 1 | 2011 | 301 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2015 | 2450 | 0.020 |
Why?
|
| Cell Proliferation | 2 | 2013 | 7226 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 1 | 2009 | 279 | 0.020 |
Why?
|
| 3' Untranslated Regions | 1 | 2009 | 343 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2015 | 5395 | 0.020 |
Why?
|
| Jurkat Cells | 1 | 2007 | 311 | 0.020 |
Why?
|
| K562 Cells | 1 | 2007 | 338 | 0.020 |
Why?
|
| Positron-Emission Tomography | 1 | 2015 | 2173 | 0.020 |
Why?
|
| Plasmids | 1 | 2007 | 837 | 0.020 |
Why?
|
| DNA Primers | 1 | 2007 | 1399 | 0.020 |
Why?
|
| Transfection | 1 | 2009 | 2944 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2013 | 5710 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2009 | 1694 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2009 | 1538 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2009 | 2084 | 0.010 |
Why?
|
| Survival Rate | 1 | 2015 | 12221 | 0.010 |
Why?
|
| Cell Line | 1 | 2009 | 5114 | 0.010 |
Why?
|
| Gene Expression | 1 | 2009 | 3570 | 0.010 |
Why?
|
| Pregnancy | 1 | 2013 | 7573 | 0.010 |
Why?
|
| Base Sequence | 1 | 2007 | 4917 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2013 | 5270 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2009 | 6009 | 0.010 |
Why?
|
| Humans | 5 | 2015 | 261506 | 0.010 |
Why?
|
| Male | 2 | 2015 | 123000 | 0.010 |
Why?
|
| Female | 2 | 2015 | 141928 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2013 | 14289 | 0.010 |
Why?
|